Bharat Biotech updates Covaxin efficacy to 65.2% against Delta variant
Bharat Biotech has updated the efficacy of Covaxin to 65.2% against the Delta variant in - Effectiveness Study on Delta Variant - Lancet Infectious Diseases, published on Nov 23 2021.
"Bharat Biotech commends the investigators from the All India Institute of Medical Sciences (AIIMS) on the BBV152 study published in Lancet Infectious Diseases. These results provide evidence for effectiveness for Covaxin in real life settings," Bharat Biotech said. Read more
ITC starts clinical trials for nasal spray to prevent Covid-19 infection
Diversified conglomerate, ITC, is developing a nasal spray for Covid-19 prevention for which it has initiated clinical trials.
PM Modi says Jewar airport will be 'logistics gateway for north India'
Taking a swipe at previous governments, Prime Minister Narendra Modi on Thursday said Uttar Pradesh was kept in deprivation and darkness earlier but it is now getting what it always deserved and is making its mark internationally under a "double-engine" BJP rule.
After laying the foundation stone for the Noida International Airport at Jewar in Uttar Pradesh, which would one of the largest aerodromes in Asia, Modi highlighted the development activities in the poll-bound state and said the new airport will help the state become an export-centre whereby even MSMEs will have easier access to overseas markets. Read more
BlackRock, Canada Pension bought more Paytm stock after weak market debut
Several of the biggest investors in Paytm’s record-breaking initial public offering added to their stakes in the Indian fintech giant after shares plunged by as much as 41%, according to people familiar with the matter.
BlackRock Inc. and Canada Pension Plan Investment Board were among so-called anchor investors in the IPO that bought more Paytm shares on Tuesday and Wednesday, the people said, asking not to be identified discussing private information. Read more